NewDrug is a start-up Biotechnology Company established in January 2017, with expertise in Drug Discovery and Development. It is located at the Patras Science Park, Greece.

The company focuses its activities towards the development of active peptides and mimetics for clinical investigation based on high tech expertise of the founders and the supporting Network.

The company bases its capital potential on Expertise, Technology and Patents of its Founders:

Professors John Matsoukas and Vasso Apostolopoulos, and Dr. Minos Matsoukas and Dr. Theodora Katsila.

The company focuses on methodologies for the design and development of active peptides and mimetics for clinical investigation.